Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Acquired by XTX Topco Ltd

XTX Topco Ltd lifted its holdings in shares of Rockwell Medical, Inc. (NASDAQ:RMTI) by 45.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,455 shares of the company’s stock after purchasing an additional 8,922 shares during the quarter. XTX Topco Ltd owned about 0.09% of Rockwell Medical worth $113,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Armistice Capital LLC boosted its stake in Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after buying an additional 592,000 shares during the period. Jane Street Group LLC acquired a new position in shares of Rockwell Medical in the 3rd quarter worth approximately $534,000. Walleye Capital LLC purchased a new position in shares of Rockwell Medical during the 3rd quarter worth approximately $435,000. Renaissance Technologies LLC increased its holdings in Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after purchasing an additional 92,189 shares during the last quarter. Finally, Corsair Capital Management L.P. purchased a new stake in Rockwell Medical in the third quarter valued at approximately $298,000. 23.31% of the stock is owned by institutional investors and hedge funds.

Rockwell Medical Trading Up 1.5 %

NASDAQ:RMTI opened at $2.08 on Friday. Rockwell Medical, Inc. has a 12-month low of $1.16 and a 12-month high of $5.15. The firm has a market cap of $67.22 million, a PE ratio of -41.60 and a beta of 1.38. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $2.89 and a 200 day moving average price of $2.70.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on RMTI. RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. HC Wainwright dropped their target price on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Monday, November 25th. StockNews.com cut shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday. Finally, Rodman & Renshaw started coverage on shares of Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective for the company.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.